Ciliopathy Alliance
Private, Limited by guarantee, no share capital, use of 'Limited' exemption · London
ActiveUnited KingdomIncorporated 2011Private, Limited by guarantee, no share capital, use of 'Limited' exemption
Documents & history
Available account evidence and business events. This is not a complete filing history or document library.
Accounts to 2025-03-31
IXBRL · 38 source facts · 14 selected values
Validation findingsXBRL valid
Accounts to 2025-03-31
IXBRL · 38 source facts · 14 selected values
Validation findings
XBRL valid
- Reporting period
- 2024-04-01 to 2025-03-31
- Extraction status
- complete
- Numeric facts
- 18
- Documents processed
- 1
- XBRL standards validation
- valid
- Filing-profile validation
- invalid
- Parser
- arelle 2.44.4
- Taxonomy
- FRS-102-2023-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_2511_07842342_20250331
- Source archive
- Accounts_Monthly_Data-November2025.zip
Extraction findings: filing rules invalid. These describe source processing, not an audit opinion on the company.
Accounts to 2024-03-31
IXBRL · 36 source facts · 16 selected values
Not assessedlegacy record
Accounts to 2024-03-31
IXBRL · 36 source facts · 16 selected values
Not assessed
legacy record
- Reporting period
- 2023-04-01 to 2024-03-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 16
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2023-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_3100_07842342_20240331
- Source archive
- Accounts_Monthly_Data-November2024.zip
Accounts to 2023-03-31
IXBRL · 43 source facts · 20 selected values
Not assessedlegacy record
Accounts to 2023-03-31
IXBRL · 43 source facts · 20 selected values
Not assessed
legacy record
- Reporting period
- 2022-04-01 to 2023-03-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 24
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2023-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_6666_07842342_20230331
- Source archive
- Accounts_Monthly_Data-December2023.zip
Accounts to 2022-03-31
IXBRL · 33 source facts · 14 selected values
Not assessedlegacy record
Accounts to 2022-03-31
IXBRL · 33 source facts · 14 selected values
Not assessed
legacy record
- Reporting period
- 2021-04-01 to 2022-03-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 14
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2019-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0001_07842342_20220331
- Source archive
- Accounts_Monthly_Data-December2022.zip
Accounts to 2021-03-31
IXBRL · 44 source facts · 20 selected values
Not assessedlegacy record
Accounts to 2021-03-31
IXBRL · 44 source facts · 20 selected values
Not assessed
legacy record
- Reporting period
- 2020-04-01 to 2021-03-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 24
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2019-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0097_07842342_20210331
- Source archive
- Accounts_Monthly_Data-December2021.zip
Accounts to 2020-03-31
IXBRL · 42 source facts · 20 selected values
Not assessedlegacy record
Accounts to 2020-03-31
IXBRL · 42 source facts · 20 selected values
Not assessed
legacy record
- Reporting period
- 2019-04-01 to 2020-03-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 24
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2014-09-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0085_07842342_20200331
- Source archive
- Accounts_Monthly_Data-December2020.zip
Accounts to 2019-03-31
IXBRL · 40 source facts · 18 selected values
Not assessedlegacy record
Accounts to 2019-03-31
IXBRL · 40 source facts · 18 selected values
Not assessed
legacy record
- Reporting period
- 2018-04-01 to 2019-03-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 22
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2014-09-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0073_07842342_20190331
- Source archive
- Accounts_Monthly_Data-December2019.zip
Accounts to 2013-03-31
IXBRL · 26 source facts · 6 selected values
Not assessedlegacy record
Accounts to 2013-03-31
IXBRL · 26 source facts · 6 selected values
Not assessed
legacy record
- Reporting period
- 2011-11-10 to 2013-03-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 8
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- uk-gaap-main-2009-09-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_9993_07842342_20130331
- Source archive
- Accounts_Monthly_Data-August2013.zip
Registered details
07842342- Status
- Active
- Type
- Private, Limited by guarantee, no share capital, use of 'Limited' exemption
- Incorporated
- 2011-11-10
- Jurisdiction
- —
- Registered office
- INSTITUTE OF CHILD HEALTH, 30 GUILDFORD STREET, LONDON, WC1N 1EH, ENGLAND
Classification
1 SIC codes53103
Capital & company events
Reconstructed equity rounds and matched research funding.
Equity fundraising
0 SH01-derived roundsNo reconstructed allotment rounds.
Research and innovation
4 matched grantsRare Disease Research Platform: The renal ciliopathies national network (RCNN)ActiveMRC · Research Grant · 2023-07-02 – 2029-01-02 · with 12 other participants£1,267,380whole project
Rare Disease Research Platform: The renal ciliopathies national network (RCNN)Active
MRC · Research Grant · 2023-07-02 – 2029-01-02 · with 12 other participants
£1,267,380
whole project
Newcastle UniversityleadBbs UKBoston Children's HospitalBrunel University LondonCiliopathy AllianceEmboNatnl Reg of Rare Kidney Dis RaDaRNucleic Acid Therapy AcceleratorPolycystic Kidney Disease CharityThe Renal AssociationUniversity College LondonUniversity Of DundeeUniversity of Leeds
Therapies for Renal CiliopathiesLeadLive
Innovate UK · EU-Funded · 2023-07-01 – 2027-06-30
£27,822
awarded
Therapies for Renal CiliopathiesLeadActive
Horizon Europe Guarantee · EU-Funded · 2023-06-30 – 2027-06-29
£27,822
whole project
Therapies for Renal CiliopathiesActive
Horizon Europe Guarantee · EU-Funded · 2023-06-30 – 2027-06-29
£27,822
whole project